Traditional Chinese Medicine FYTF-919 (Zhongfeng Xingnao Oral Prescription) for the Treatment of Acute Intracerebral Hemorrhage: A Methodological Appraisal of the CHAIN Trial.

作者
Arthur Yin Fan,Sherman Gu,Changzhen Gong,Suhong Xiao,Yadi Tan,Haihe Tian,Tzi Chiang Lin,Hui Wei
出处
期刊:PubMed [National Institutes of Health]
卷期号:32 (1): 42-51
链接
标识
摘要

Context: The Lancet report of the CHAIN trial evaluating FYTF-919, a traditional Chinese medicine (TCM) for moderate to severe acute intracerebral hemorrhage, concluded "no effect" on functional recovery, survival, and health-related quality of life compared to placebo. Objective: The current study intended to re-examine its methodology and conclusions about the efficacy of FYTF-919. Design: Reanalysis of data from the Lancet report. Intervention: Adopting the PICO framework and the CONSORT Extension, a critical appraisal of the trial's report and supplementary materials was conducted. Definition of TCM-specific patterns, sample size calculation, use of multiple concomitant therapies, timing of primary outcome assessment, and interpretation of results have been examined. Results: There was a risk of performance bias in the trial as it did not report TCM-specific patterns, despite FYTF-919 being formulated for qi deficiency, potentially including patients unsuitable for this intervention. The sample size calculation was flawed and inconsistently applied, altering the mean difference and potentially underestimating FYTF-919's effect. Both the FYTF-919 and placebo groups had 19 concomitant therapies applied as needed, making it difficult to isolate FYTF-919's benefits. The study mistakenly hypothesized that there was no difference between the two groups due to the use of the 19 concomitant therapies, referred to as "routine treatment". The main report ignored multiple significant differences in subgroups and at earlier timepoints. These potentially positive findings were not highlighted, raising concerns of a substantial risk of selective reporting bias. Conclusions: The trial's conclusion of "no effect" is questionable due to methodological flaws, trial design, and reporting errors. Proper assessment of complex interventions, clearer adherence to TCM-specific guidelines, rigorous sample size calculation, and balanced consideration of early recovery data and subgroups are essential. The current analysis of the appraisal found that the effect of the FYTF-919 was superior to that of the placebo. Keywords: Intracerebral hemorrhage, Traditional Chinese Medicine, FYTF-919, multiple interventions, CHAIN trial, selective report bias, critical appraisal, Zhongfeng Xingnao.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Claire完成签到,获得积分10
刚刚
刚刚
刚刚
Novoa的应助被小鹿采纳,获得10
刚刚
科研通AI6.4的应助被DRJ采纳,获得10
1秒前
1秒前
茄子回锅肉完成签到,获得积分10
1秒前
从容冬灵完成签到,获得积分10
1秒前
1秒前
hh完成签到,获得积分10
2秒前
李健的应助被甜美的淇采纳,获得10
2秒前
2秒前
lcc李川川完成签到,获得积分10
2秒前
123完成签到,获得积分20
2秒前
yemiao发布了新的文献求助10
2秒前
2秒前
2秒前
3秒前
3秒前
keyby发布了新的文献求助30
3秒前
万能图书馆的应助被椰子鸡采纳,获得10
4秒前
4秒前
jolly0304发布了新的文献求助10
4秒前
libai完成签到,获得积分10
4秒前
Orange的应助被AIA7采纳,获得10
4秒前
王迪发布了新的文献求助10
4秒前
瘦瘦的夏旋完成签到 ,获得积分10
4秒前
多情寒珊发布了新的文献求助10
5秒前
欣慰火完成签到,获得积分10
5秒前
Ohhhh关注了科研通微信公众号
5秒前
5秒前
5秒前
马111发布了新的文献求助10
5秒前
5秒前
6秒前
上官若男的应助被卜卜卜卜卜采纳,获得10
7秒前
7秒前
墨小芃发布了新的文献求助10
7秒前
efls发布了新的文献求助30
8秒前
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8161749
求助须知:如何正确求助?哪些是违规求助? 9556240
关于积分的说明 21733360
捐赠科研通 7751657
什么是DOI,文献DOI怎么找? 3427566
关于科研通互助平台的介绍 2552632
邀请新用户注册赠送积分活动 2472047